Ilko Menkov
@Vestal Point Capital, Lp
Latest period2024 - Q3ReportedManaged Assets$1.319BTotal holdings69
Assets growth rate-1.67%Assets growth rate (2-Q avg)4.62%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Vestal Point Capital, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 69 positions.
Assets under management
The assets under management (AUM) of Vestal Point Capital, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.319B in assets, with a quarterly growth rate of -1.67% and a 2-quarter average growth rate of 4.62%. The portfolio is managed by Ilko Menkov, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
INSPInspire Medical Systems Inc
| 0% | $8.03M 60,000 shares@ $133.83 avg price | Exited |
PCRXPacira Biosciences Inc
| 0% | $8.011M 280,000 shares@ $28.61 avg price | Exited |
DYNDyne Therapeutics Inc
| 0% | $7.94M 225,000 shares@ $35.29 avg price | Exited |
FULCFulcrum Therapeutics Inc
| 0% | $7.192M 1.16M shares@ $6.2 avg price | Exited |
IOVAIovance Biotherapeutics Inc
| 0% | $2.406M 300,000 shares@ $8.02 avg price | Exited |
NAMSNewamsterdam Pharma Co Nv
| 0% | $480,250 25,000 shares@ $19.21 avg price | Exited |